Jaihind Industries incorporates healthcare subsidiary with 78% stake

Jaihind Industries Limited has incorporated a wholly-owned subsidiary named Wellness & Medicinal Oasisz Private Limited with a 78% shareholding. The subsidiary was registered with the Registrar of Companies on May 13, 2026, as per a Certificate of Incorporation. The company disclosed this information under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The newly incorporated entity operates in the healthcare and pharmaceutical industry. As it is a recently established company, it has not yet commenced business operations, and its turnover is currently nil. The registered office of Wellness & Medicinal Oasisz Private Limited is located in Mumbai, India.

Financial Details of the Subsidiary

The financial structure of the subsidiary includes an authorized and paid-up capital of ₹1,00,000. This capital is divided into 10,000 equity shares with a face value of ₹10 each. The cost of acquisition for the 78% stake was ₹78,000, which was paid through cash consideration.

Particulars	Description
Name of Subsidiary	Wellness & Medicinal Oasisz Private Limited
CIN	U86100MR2026PTC476576
Date of Incorporation	May 13, 2026
Authorized Capital	₹1,00,000
Paid-up Capital	₹1,00,000
Cost of Acquisition (78%)	₹78,000

Strategic Objectives

The incorporation of this subsidiary aligns with Jaihind Industries' strategy to expand its footprint in the healthcare and pharmaceutical sectors. The company aims to explore opportunities in hospital infrastructure, medical services, wellness, healthcare management, and allied activities through this new venture. Management expects this move to strengthen its long-term business portfolio and create growth opportunities within the healthcare industry.

The transaction does not fall under related party transactions, and no specific governmental or regulatory approvals were required for the acquisition. The promoter and promoter group have no interest in the transaction other than what has been disclosed.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+4.39%	+0.71%	+9.87%	-11.51%	-24.72%	+586.69%

Jaihind Industries Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.

Regulatory Compliance Submission

The company submitted the certificate under Regulation 74(5) of SEBI regulations on April 13, 2026, through Director Dinesh Jayantlal Doshi. The certificate was issued by Skyline Financial Services Pvt. Ltd., which serves as the Registrar and Share Transfer Agent for jaihind synthetics .

Dematerialization Activity Summary

The quarterly report reveals the company's dematerialization activities for the period from January 1, 2026 to March 31, 2026. The data shows efficient processing of share transfer requests with complete acceptance rates.

Activity Type:	Quantity	Number of Requests
Quantity Downloaded:	100	1
Quantity Rejected:	0	0
Quantity Accepted:	100	1

Share Transfer Details

The quarter witnessed one dematerialization request from shareholder Rishabh Damani for 100 equity shares. The request, received on January 12, 2026, was processed efficiently with confirmation completed on January 14, 2026, taking 3 days for processing.

Regulatory Confirmation

Skyline Financial Services Pvt. Ltd. confirmed that all securities comprised in the certificates have been properly listed on the stock exchange where earlier issued securities are traded. The certificate also verified that after due verification, the physical certificates were mutilated and cancelled, with the depository name substituted in records as the registered owner within the stipulated 15-day period.